Aria’s Army

Run by her daddy, BS molecular biology, BBA business, MD, dedicated to finding cure for severe autism spectrum disorder, posts are daddy’s own

[Aria’s Army @johnchicago]

@emilykmay My daughter is also non-verbal severe ASD. I am MD with BS in molecular biology . Dont like RFK but like the attention it brings to our kids. We are trying leucovorin - study published in Nature showing benefit for ASD. Watching NNZ-2591 trials from Neuren as well.

[Aria’s Army @johnchicago]

@adamfeuerstein You are a political science major with no background in science or journalism or statistics and it shows. You couldn't dismantle an IKEA bookshelf.

[Aria’s Army @johnchicago]

Neuren Pharmaceuticals announced succes in Phase 2 trial for Phelan-McDermid, a form of autism. The drug NNZ-2592 is an analog of trofinetide which worked in Rett Syndrome. Why not a trial in autism???!!! https://t.co/95ufi88teV

[TACA @TACAfoundation]

From 5 to 13% of all kids with disabilities. Another marker that #autism is an epidemic.

https://t.co/tJZMzgitsW

[Thinking Autism @TweetingAutism]

It's clearly outrageous to erase children with complex needs from the school photo.

But where is the outrage about children/adults with #profoundautism who are largely erased from public discourse, media representation, and even most scientific research?
https://t.co/TaW4HTzvHx

[Aria’s Army @johnchicago]

Marvel Biosciences Invited to Test MB-204 on Autism by French University https://t.co/woRwVi5kyj via @YahooFinance

[International Rett Syndrome Foundation @Rettsyndrome]

Today, during their quarterly financial call, @TayshaGTx shared updates and early interim data from the first two adult participants dosed with their investigational gene therapy TSHA-102 in the REVEAL Adult Study. Read the full press release here: https://t.co/ve7GMjyBf7

[Aria’s Army @johnchicago]

More evidence of microglia involvement with ASD

https://t.co/34cA0bgFFE

[Allen Frances @AllenFrancesMD]

My biggest DSM-IV regret:
Our broadening the autism definition that has led to such masssive, careless over-diagnosis. https://t.co/LfdzoL48NQ

[Aria’s Army @johnchicago]

Researchers ID Four Distinct Subtypes of Autism https://t.co/DYe86hlcAz via @clinicalomics

[Judith U @Autismville]

For my son, Jack, and all who struggle with profound autism, today (and every day) I see you.

[TACA @TACAfoundation]

Important announcement:
New CDC #autism prevalence is 1 in 36
#epidemic #timetocare #timetoact #417percentincrease
https://t.co/BPurN2d4Bq

[Spectrum (Autism Research News) @Spectrum]

If approved, trofinetide will be the first-ever drug for the neurodevelopmental condition Rett syndrome. @acadiapharma is "eager" for 12 March, the day the FDA will issue its decision.

By @DrShaena.
@brimblem
https://t.co/3vsaqopHDX

[International Rett Syndrome Foundation @Rettsyndrome]

BREAKING NEWS -
@NeurogeneInc just announced that the FDA approved their IND to launch a clinical trial for their #genetherapy treatment NGN-401. It will launch in the US in 2023 for pediatric females with #Rettsyndrome. Learn more here: https://t.co/EDZgUF9ivm

[Thinking Autism @TweetingAutism]

#HappyNewYear to families affected by #autism everywhere. Let's hope 2023 brings new impetus to research into treatments for disabling #ASD symptoms in order to help achieve a better quality of life for individuals with autism.

[Aria’s Army @johnchicago]

Thank you Yale for developing a feasible biomarker for autism clinical trials! https://t.co/4WBilyiaBJ

[Aria’s Army @johnchicago]

Good luck to Northwestern on this trial for Phelan-McDermid! Hope this works for the whole spectrum. https://t.co/EQbU1kcsSM

[Spectrum (Autism Research News) @Spectrum]

“Amongst all this heterogeneity and all these differences in autism, there might be some common driver,” says study investigator Smrithi Prem.

By @avaskham.
@biorxivpreprint: https://t.co/Zv9memtEwB
@david_sulzer @PeterCrino @Premsm2020
https://t.co/pe01nONhcF

[MAKE A STAND 4 AUTISM @MakeAStandOrg]

#autism #neurodiversity

[Aria’s Army @johnchicago]

Yet more evidence of mTOR's effect on ASD - unfortunately, rapamycin did not work in tuberous sclerosis

Autism subgroups converge on cell growth pathway https://t.co/aMcBrml8w5 via @Spectrum